IHE Holdings Information

IHE is an equity ETF with a total of 60 individual holdings. The top holdings are Johnson & Johnson stock at 22.16%, Eli Lilly and Company at 21.65%, Merck & Co. at 4.95%, Bristol-Myers Squibb Company at 4.66%, and Royalty Pharma at 4.39%.

Total Holdings

Top 10 Percentage

75.60%

Asset Class

Equity

ETF Category

Health

Assets

1.74B

PE Ratio

24.33

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	JNJ	Johnson & Johnson	22.16%	1,426,758
2	LLY	Eli Lilly and Company	21.65%	299,424
3	MRK	Merck & Co., Inc.	4.95%	571,446
4	BMY	Bristol-Myers Squibb Company	4.66%	1,223,984
5	RPRX	Royalty Pharma plc	4.39%	1,248,229
6	PFE	Pfizer Inc.	4.29%	2,658,338
7	VTRS	Viatris Inc.	3.99%	4,291,479
8	ZTS	Zoetis Inc.	3.65%	837,169
9	JAZZ	Jazz Pharmaceuticals plc	3.34%	231,213
10	ELAN	Elanco Animal Health Incorporated	2.52%	1,840,517
11	CORT	Corcept Therapeutics Incorporated	2.48%	352,085
12	AXSM	Axsome Therapeutics, Inc.	1.93%	159,293
13	CRNX	Crinetics Pharmaceuticals, Inc.	1.91%	388,556
14	DFTX	Definium Therapeutics, Inc.	1.26%	477,787
15	LGND	Ligand Pharmaceuticals Incorporated	1.23%	73,853
16	LQDA	Liquidia Corporation	1.07%	258,760
17	INDV	Indivior Pharmaceuticals, Inc.	0.99%	449,397
18	OGN	Organon & Co.	0.77%	968,148
19	AMLX	Amylyx Pharmaceuticals, Inc.	0.72%	311,292
20	EWTX	Edgewise Therapeutics, Inc.	0.70%	277,686
21	ELVN	Enliven Therapeutics, Inc.	0.69%	200,784
22	AMRX	Amneal Pharmaceuticals, Inc.	0.66%	635,087
23	TARS	Tarsus Pharmaceuticals, Inc.	0.61%	145,978
24	SUPN	Supernus Pharmaceuticals, Inc.	0.59%	213,937
25	NKTR	Nektar Therapeutics	0.54%	124,550

Showing 25 of 60 holdings

Subscribe to see the full list

Activate Now

As of Aug 20, 2026